Assignee
GEN1E LIFESCIENCES INC
US·11 granted patents·6 pending applications·26 citations·filing 2021–2025
Top patents by PatentIndex Score
17 records- 0196US11286260B2P38α mitogen-activated protein kinase inhibitorsGEN1E LIFESCIENCES INC·Filed 2021·Granted Mar 29, 2022·12 cites·30 claims
- 0295US11555020B2Substituted naphthyl p38α mitogen-activated protein kinase inhibitorsGEN1E LIFESCIENCES INC·Filed 2022·Granted Jan 17, 2023·4 cites·22 claims
- 0395US11440918B2p38α mitogen-activated protein kinase inhibitorsGEN1E LIFESCIENCES INC·Filed 2022·Granted Sep 13, 2022·5 cites·29 claims
- 0495US11390581B2Crystalline 5-(dimethylamino)-n-(4-(morpholinomethyl)phenyl)naphthalene-1-sulfonamide di-hydrochloride di-hydrateGEN1E LIFESCIENCES INC·Filed 2021·Granted Jul 19, 2022·2 cites·27 claims
- 0591US11926635B2P38α mitogen-activated protein kinase inhibitorsGEN1E LIFESCIENCES INC·Filed 2022·Granted Mar 12, 2024·1 cites·35 claims
- 0688US12116353B1Crystalline chloro-n-(4-(morpholinomethyl)phenyl)benzamide and crystalline hydrochloride saltGEN1E LIFESCIENCES INC·Filed 2024·Granted Oct 15, 2024·2 cites·15 claims
- 0784US12331024B2Substituted naphthyl P38alpha mitogen-activated protein kinase inhibitorsGEN1E LIFESCIENCES INC·Filed 2024·Granted Jun 17, 2025·0 cites·32 claims
- 0882US12404259B2Inhibitors of extracellular signal-regulated kinaseGEN1E LIFESCIENCES INC·Filed 2024·Granted Sep 2, 2025·0 cites·12 claims
- 0982US2024182486A1P38alpha mitogen-activated protein kinase inhibitorsGEN1E LIFESCIENCES INC·Filed 2024·Application pending·0 cites
- 1080US12595243B2Modulators of extracellular signal-regulated kinaseGEN1E LIFESCIENCES INC·Filed 2024·Granted Apr 7, 2026·0 cites·17 claims
- 1179US11976049B2Substituted naphthyl p38alpha mitogen-activated protein kinase inhibitorsGEN1E LIFESCIENCES INC·Filed 2022·Granted May 7, 2024·0 cites·17 claims
- 1279US2025270176A1Substituted naphthyl p38alpha mitogen-activated protein kinase inhibitorsGEN1E LIFESCIENCES INC·Filed 2025·Application pending·0 cites
- 1377US2025353826A1Inhibitors of extracellular signal-regulated kinaseGEN1E LIFESCIENCES INC·Filed 2025·Application pending·0 cites
- 1474US2025243154A1Crystalline 5-(dimethylamino)-n-(4-(morpholinomethyl)phenyl)naphthalene-1-sulfonamide di-hydrochloride di-hydrateGEN1E LIFESCIENCES INC·Filed 2025·Application pending·0 cites
- 1573US12269792B2Crystalline 5-(dimethylamino)-N-(4-(morpholinomethyl) phenyl)naphthalene-1-sulfonamide di-hydrochloride di-hydrateGEN1E LIFESCIENCES INC·Filed 2022·Granted Apr 8, 2025·0 cites·20 claims
- 1671US2025333387A1Crystalline chloro-n-(4-(morpholinomethyl)phenyl)benzamide and crystalline hydrochloride saltGEN1E LIFESCIENCES INC·Filed 2024·Application pending·0 cites
- 1768US2025095774A1Machine learning methods and systems for acute respiratory distress syndrome patient sub-phenotypingGEN1E LIFESCIENCES INC·Filed 2024·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when GEN1E LIFESCIENCES INC files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →